Percutaneous brachytherapy for small-sized non-small cell lung cancer.
A patient with a small-sized pulmonary adenocarcinoma was successfully treated by percutaneous high dose rate interstitial brachytherapy alone. The patient, who had an adenocarcinoma with 12-mm diameter in the lingular lobe of left lung, was judged to be inoperable because of poor pulmonary function due to emphysema and extensive pleural adhesion. The tumor was punctured with a 21-gauge fine applicator needle followed by the introduction of an iridium 192 (192Ir) radioactive source through the applicator needle using a remote afterloader. The tumor was irradiated for 225.1 s in one fraction. The tumor was in the inside of the iso-dose line of 40 Gy. The delivered doses calculated at nine reference points, which were 12.5 mm distant from the center of the tumor, distributed between 19.225 and 32.169 Gy, with a mean of 24.8 Gy. No apparent side effect including pneumothorax and hemoptysis was observed. The tumor shrank and showed no increment of the size for about 2 years.
Imamura
F
F
Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan.
Chatani
M
M
Nakayama
T
T
Uda
H
H
Nakamura
S
S
Horai
T
T
D000279:Administration, Cutaneous; D000368:Aged; D001918:Brachytherapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy*; D006801:Humans; D007496:Iridium Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008297:Male; D011879:Radiotherapy Dosage; D016896:Treatment Outcome
D007496:Iridium Radioisotopes